Metraipolis › archive › dc_26070197ed30
Evaluation of safety and affection of variable duration of dual antiplatelet therapy using aspirin plus ticagrelor after successful percutaneous coronary… — Europe PMC PMID:41896747
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41896747
- DOI
- 10.1186/s12872-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T19:27:49.662Z
- SHA-256 of the archived text
f502256046b0e6416a096e82904046b66f295d1ce86deb31a2f5ca9df7332703- Stable URL of this page
https://metraipolis.com/documento/dc_26070197ed30
How to cite
Evaluation of safety and affection of variable duration of dual antiplatelet therapy using aspirin plus ticagrelor after successful percutaneous coronary… — Europe PMC PMID:41896747 — Europe PMC (en), https://europepmc.org/article/MED/41896747 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_26070197ed30 (Metraipolis archive dc_26070197ed30, sha256 f502256046b0e6416a096e82904046b66f295d1ce86deb31a2f5ca9df7332703)
BibTeX
@misc{dc26070197ed30,
title = {Evaluation of safety and affection of variable duration of dual antiplatelet therapy using aspirin plus ticagrelor after successful percutaneous coronary… — Europe PMC PMID:41896747},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41896747},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_26070197ed30; sha256 f502256046b0e6416a096e82904046b66f295d1ce86deb31a2f5ca9df7332703},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41896747. Agents can read the archived copy with the MCP tool read_document.